AGP Executive Report
Last update: 6 hours agoCBD Access: MediPharm Labs shipped its first CBD metered-dose inhalers to Panama, expanding its regulated medical supply network. Tilray Medical also won approval to conduct quality testing at its Portugal facility, a move it says could speed product releases to global markets. Research: A trial found regular cannabis users reported similar stress relief after vaping a placebo or THC, while a Cochrane review says support for medical cannabis as an insomnia treatment remains uncertain. Health: Cannabis-related hospitalisations in Victoria have risen 49% in a decade. A federally funded study, meanwhile, found medical cannabis eased cancer-related symptoms and helped reduce opioid use. Hemp Policy: Proposed federal THC-product restrictions are raising alarms for North Carolina’s hemp industry, estimated at more than $3 billion.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.